Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 36.07% vs -20.43% in Jun 2026
Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 73.34% vs -45.71% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 116.28% vs -57.75% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is 0.00% vs 0.00% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
Compare Quarterly Results Of Jenburkt Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 36.07% vs -20.43% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 6.06% vs 10.53% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 73.34% vs -45.71% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 0.49% vs 5.83% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 116.28% vs -57.75% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -0.61% vs 14.61% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 0.00% vs 0.00% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 18.18% vs -8.33% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025